{
  "compound_analysis": {
    "mechanistic_coherence": {
      "overall_score": 0.7262461796817071,
      "coherence_category": "MEDIUM_COHERENCE",
      "category_scores": {
        "genotype_pathogenicity": 0.9623912499999999,
        "structure_function": 0.56972,
        "pathway_enrichment": 0.8304614687268287,
        "clinical_translatability": 0.542412
      },
      "causal_trace": [
        {
          "step": 1,
          "level": "molecular",
          "description": "TP53 variant p.Arg175His (chr17:17498) classified as Likely_Pathogenic by AlphaMissense (score: 0.980) and Pathogenic by ClinVar, indicating high pathogenicity risk"
        },
        {
          "step": 2,
          "level": "molecular",
          "description": "BioPython applied variant to reference protein sequence (45749 amino acids), enabling structural impact prediction and sequence-based analysis"
        },
        {
          "step": 3,
          "level": "pathway",
          "description": "GSEApy pathway enrichment analysis of 448 pathways identified 413 significant pathways. Top enriched: p53_signaling (1.96), DNA_repair (1.46), Apoptosis (0.97), suggesting dysregulated cellular processes"
        },
        {
          "step": 4,
          "level": "molecular",
          "description": "ProteinMPNN (ProteinMPNN_v_48_020) structural analysis shows moderate binding site score (0.450) and good structural plausibility (1.251), indicating moderate druggability potential"
        },
        {
          "step": 5,
          "level": "clinical",
          "description": "GTEx tissue-specific analysis shows TP53 in Breast_Mammary_Tissue (TPM: 1.00). Cross-scale consistency: moderate (0.612), supporting clinical relevance assessment"
        }
      ]
    }
  }
}